New blood test could be useful in discovering pancreatic cancer in the first stadium of the disease and offer hope for more effective fight against this aggressive type of tumor that is often diagnosed too late, the results of the study that has been published in Science Transitional Medicine magazine have shown.
“The discovery of bio marker or bio chemical trace for that disease could radically change the perspective for patients”, doctor Ken Zarett has said, the director of Penn institute for regenerative medicine.
“It has been shown that early discovery of a tumor has had a strong effect for reducing the deadly outcomes for patients that have had different types of cancer, including breast cancer, colon caner and uterus” – Zarett has said.
“Unfortunately, people who have had pancreatic cancer have often been diagnosed too late to be undertaken a surgery and medicated effectively” – he added.
According to the latest data, 4 out of 5 patients die up to 12 months after the diagnoses, and the rate of survival in a 5 year period is only 5%.
In order to find bio markers in blood which would spot the pancreatic cancer, the scientists have been using technology in which they used stem cells and pancreatic cells that fell ill with cancer.
The connection of two bio markers has allowed for diagnosis of tumor in extremely early phase which has a lot more effect than all other know methods today.
New blood test will maybe be of a life importance for people who have pancreatic cancer running in their bloodline.